OrbiMed Capital GP VII LLC, Director at Repare Therapeutics Inc. (RPTX), sold 8,084 shares at $33.93 ($275K) on 2021-09-07, disclosed to the SEC on 2021-09-08.
Scheduled sale ($275k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.00 | 212 | $7K | 2.6% |
| 2 | $34.00 | 6,985 | $237K | 86.4% |
| 3 | $33.93 | 26 | $882 | 0.3% |
| 4 | $33.93 | 861 | $29K | 10.6% |
| Total | $33.99 avg | 8,084 | $275K | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |